View clinical trials related to Pneumonia in Children.
Filter by:The current work aims to: 1. Measure the levels of Neutrophil CD64 Receptor, Monocyte Human Leukocyte Antigen-DR (mHLA-DR), and Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) in children suffering from pneumonia. 2. Compare these levels to their levels in healthy control children. 3. Analyze the cut-off point, sensitivity, specificity, and area under the ROC curve of these biomarkers to test their abilities to early differentiate children with pneumonia from healthy control children. 4. Conclude or reject their possible use as diagnostic and/or prognostic markers in pediatric pneumonia.
This is a randomized, prospective study to determine if there is a difference in hospital length of stay between patients receiving continuous hardwire cardiorespiratory monitoring and those receiving intermittent vital signs measurements among pediatric patients admitted for uncomplicated respiratory illness.
This study is to test the usability of a new pulse oximeter probe designed for children 0-5 years.